The purpose of this study is: * To define The differences of bio-chemical phenotypes in chronic airway inflammatory diseases. * To identify novel biomarkers in chronic airway inflammatory diseases as a screening, diagnostic, or monitoring marker.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.